Bedrocan International visit to Australia and New Zealand

A lot has happened in Australia and New Zealand to improve patient access to cannabis-based medicines. In this region, Bedrocan maintains is mission – to bridge the gap between patients need for cannabis and the requirements of modern medicines.

Reaching out to Oceania

Bedrocan have built strong academic and private partnerships across the globe. Our experienced international team, networks and collaborations are being strengthened here in Australia and New Zealand. Our international team are set to meet with leading researchers and practitioners who seek a better understanding of medicinal properties, the medicines safe and effective use, and education without commercial bias.

Steadfast, not a start-up

Bedrocan Australia draws on our 20+ years’ experience and global network. As the world’s most experienced producer of legal medicinal cannabis, our intention has always been for cannabis flos to achieve official medicine registration.

The first step is good manufacturing practice (GMP). Achieving a major industry milestone, Bedrocan is the only cannabis cultivator with end-to-end GMP. This guarantees seamless GMP production of finished dose forms – just like any other medicine.

Bedrocan’s founders – Tjalling Erkelens and Wupke Bruining – will be in Australia and New Zealand during late June and early July 2017.